Table 1.

Summary of the clinical characteristics of the participants including demographics and concomitant medical conditions.

Population Demographics	No. Of participants (%)			p-value
	Overall (n = 64)	Survived (n = 53)	Deceased (n = 11)
Age (years)	66.4 ± 15.6	65.6 ± 14.9	70.6 ± 18.8	0.33
Age at diagnosis (years)	61.0 ± 16.0	59.5 ± 15.1	69.0 ± 19.2	0.09
Smoker	12 (18.8)	10 (18.9)	2 (18.2)	1.0
Male Gender	39 (60.9)	30 (56.6)	9 (81.8)	0.22
Ethnicity				0.08
Chinese	45 (70.3)	37 (69.8)	8 (72.7)
Malay	9 (14.1)	8 (15.1)	1 (9.1)
Indian	3 (4.7)	1 (1.9)	2 (18.2)
Others	7 (10.9)	7 (13.2)	0 (0.0)
Body Mass Index (kg/m2)	24.4 ± 6.0	24.6 ± 6.0	23.4 ± 5.8	0.58
Concomitant Medical Conditions
Cardiovascular Risk Factors
Hypertension	29 (45.3)	22 (41.5)	7 (63.6)	0.31
Hyperlipidaemia	25 (39.1)	18 (34.0)	7 (63.6)	0.14
Diabetes Mellitus	11 (17.2)	6 (11.3)	5 (45.5)	0.02
Peripheral Vascular Disease	1 (1.6, n = 63)	0 (0.0, n = 52)	1 (9.1)	0.39
Cardiac
Ischaemic Heart Disease	7 (10.9)	2 (3.8)	5 (45.5)	< 0.001
Atrial Fibrillation	2 (3.1)	1 (1.9)	1 (9.1)	0.77
Congestive Cardiac Failure	1 (1.6)	0 (0.0)	1 (9.1)	0.38
Others
Stroke/Transient Ischaemic Attack	11 (17.2)	10 (18.9)	1 (9.1)	0.73
Hemiplegic	1 (1.6)	1 (1.9)	0 (0.0)	1.0
Chronic Kidney Disease	7 (10.9)	1 (1.9)	6 (54.5)	< 0.001
Chronic Obstructive Pulmonary Disease	2 (3.1)	2 (3.8)	0 (0.0)	1.0
Malignancy	4 (6.2)	3 (5.7)	1 (9.1)	1.0
Dementia	1 (1.6)	1 (1.9)	0 (0.0)	1.0
Connective Tissue Disease	2 (3.1)	1 (1.9)	1 (9.1)	0.77
Outcomes
Deaths	11 (17.2)	-	-	-
Major Adverse Cardiovascular Events (MACE)	10 (16.1, n = 62)	3 (5.7)	7 (77.8)	< 0.001
Cardiovascular Death	5 (7.8)	0 (0.0)	5 (45.5)	< 0.001
Congestive Cardiac Failure	4 (6.5, n = 62)	1 (1.9)	3 (33.3, n = 9)	0.005
Stroke	3 (4.8, n = 62)	1 (1.9)	2 (22.2, n = 9)	0.07
Acute Myocardial Infarction	4 (6.5, n = 62)	1 (1.9)	3 (33.3, n = 9)	0.005